VRDN

Viridian Therapeutics, Inc.DE

Investor Moves

InvestorPortfolio ValuePortfolio ChangePosition ChangeAvg Buy PriceCurrent Price
Ken GriffinCitadel Advisors
$-21.8M
ExitQ1 2026
$22M
--
$17.26
Ken FisherFisher Asset Management
$35M1.8M shares
TrimQ1 2026
$21M
$19.56
$17.26
Paul Tudor Jones IITudor Investment
$-1.6M
ExitQ1 2026
$1.6M
--
$17.26
Steven CohenPoint72
$6.3M322.8k shares
TrimQ1 2026
$1.6M
$19.56
$17.26
Ken FisherFisher Asset Management
$55M1.8M shares
AddQ4 2025
$29M
$31.12
$17.26
Ken GriffinCitadel Advisors
$22M701.1k shares
AddQ4 2025
$20M
$31.12
$17.26

News

globenewswire.comViridian Metals Commences 2026 Diamond Drill Program at the Krakenglobenewswire.comJun 9globenewswire.comViridian Metals Highlights Copper-Rich Zones up to 4.15% Cu at Kraken Ahead of 2026 Drill Programglobenewswire.comJun 5gurufocus.comViridian Therapeutics to Participate in Upcoming June Investor Conferencesgurufocus.comMay 27businesswire.comViridian Therapeutics to Participate in Upcoming June Investor Conferencesbusinesswire.comMay 27globenewswire.comViridian Metals Expands Drill Program to 50 Holes at Kraken Copper-Nickel Projectglobenewswire.comMay 19